Skip to main content

Medtronic Value Stock - Dividend - Research Selection

Medtronic

ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.

 

The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.

 

The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Medtronic Reports $9B Q3 Revenue, 8.7% Growth, Reiterates FY26 Outlook

2026-02-17
Q3 non-GAAP EPS of $1.36 beats by $0.02; FY26 EPS guided to $5.62--$5.66, including $185M tariff impact.

Medtronic PLC (MDT) Q3 2026 Earnings Call Highlights: Strong Cardiovascular Growth and ...

2026-02-17
Medtronic PLC (MDT) reports robust revenue growth driven by cardiovascular advancements and strategic product launches, despite facing challenges in certain segments.

Medtronic Q3 Earnings Call Highlights

2026-02-17
Medtronic (NYSE:MDT) executives used the company’s latest earnings call to highlight accelerating growth in several product areas, progress on multiple U.S. launches, and reiterated financial guidance for fiscal 2026 while maintaining an outlook for high single-digit adjusted EPS growth in fiscal 20

Medtronic plc Q3 2026 Earnings Call Summary

2026-02-17
Moby summary of Medtronic plc's Q3 2026 earnings call

Pre-Markets in Red to Start Holiday Shortened Week

2026-02-17
Pre-Markets in Red to Start Holiday Shortened Week.

Medtronic stock falls despite Q3 beat, Gemini's C-Suite shakeup

2026-02-17
Market Catalysts Host Julie Hyman and Yahoo Finance Markets and Data Editor Jared Blikre track several of the day's top trending stock tickers, including Medtronic (MDT) shares coming under pressure despite the medical equipment developer beating earnings estimates, General Mills (GIS) slashing its full-year sales outlook, and Gemini Space Station's (GEMI) CFO, COO, and Chief Legal Officer departing from the cryptocurrency exchange. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Pre-Markets Begins Shorter Week Slowly

2026-02-17
Empire State moderates and new earnings hit the tape for Tuesday morning.

Medtronic Just Posted Its Best Quarter in 2.5 Years

2026-02-17
Medtronic (NYSE: MDT) delivered its strongest enterprise revenue growth in 10 quarters, posting 8.7% reported growth (6.0% organic) for Q3 fiscal 2026. The medical device giant beat Wall Street expectations with non-GAAP EPS of $1.36 versus the $1.35 consensus, while revenue reached $9.02 billion against $8.99 billion estimates. Cardiac Ablation Drives Outperformance The Cardiovascular Portfolio ... Medtronic Just Posted Its Best Quarter in 2.5 Years

MDT Stock Up on Q3 Earnings and Revenue Beat, Margins Down

2026-02-17
Medtronic tops Q3 revenue and EPS estimates as Cardiovascular and Diabetes drive growth, but margin contraction tempers the upbeat quarter.

Earnings live: eToro surges after Q4 profit beat, Medtronic stumbles, DTE Energy pops

2026-02-17
The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.